On the other hand, in the clinical treatment of DLBCL, sulfasalazine (SAS), a ferroptosis inducer, can inhibit GSH synthesis by suppressing SLC7A11 transport, suggesting the important role of ferroptosis in DLBCL (133). Here, SLC7A11 is linked to diffuse large B-cell lymphoma.